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Edited by Chris WhitfieldPseudomonas aeruginosa is a Gram-negative opportunistic
pathogen whose virulence is dependent on quorum sensing
(QS). DksA1, an RNA polymerase-binding transcriptional
regulator, plays a role in determining a number of phenotypes,
including QS-mediated virulence. We therefore envisioned
that DksA1 inhibitors may help to control P. aeruginosa
infection. Here, we screened a library of 6970 chemical com-
pounds and identified two compounds (henceforth termed
Dkstatins) that specifically suppressed DksA1 activity. Treat-
ment with these two compounds also substantially decreased
the production of elastase and pyocyanin, dominant virulence
determinants of P. aeruginosa, and protected murine hosts
from lethal infection from a prototype strain of P. aeruginosa,
PAO1. The Dkstatins also suppressed production of homo-
serine lactone (HSL)-based autoinducers that activate
P. aeruginosa QS. The level of 3-oxo-C12-HSL produced by
Dkstatin-treated wildtype PAO1 closely resembled that of the
ΔdksA1 mutant. RNA-Seq analysis showed that transcription
levels of QS- and virulence-associated genes were markedly
reduced in Dkstatin-treated PAO1 cells, indicating that
Dkstatin-mediated suppression occurs at the transcriptional
level. Importantly, Dkstatins increased the antibiotic suscepti-
bilities of PAO1, particularly to protein synthesis inhibitors,
such as tobramycin and tetracycline. Co-immunoprecipitation
assays demonstrated that these Dkstatins interfered with
DksA1 binding to the β subunit of RNA polymerase, pointing
to a potential mechanism of action. Collectively, our results
illustrate that inhibition of P. aeruginosa QS may be achieved
via DksA1 inhibitors and that Dkstatins may serve as potential
lead compounds to control infection.
Pseudomonas aeruginosa, an opportunistic human path-
ogen, has extensive metabolic capabilities of adapting to
diverse environments including immunocompromised human
hosts (1). In addition, P. aeruginosa commonly contains high
proportions of regulatory genes, particularly those for diverse
signal pathways that establish resistant phenotypes (1, 2).* For correspondence: Sang Sun Yoon, sangsun_yoon@yuhs.ac.
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BY license (http://creativecommons.org/licenses/by/4.0/).Stringent response (SR) is a highly conserved mechanism
across bacterial species, activated in response to nutrient
starvation (3). SR is mediated by two key elements, nucleotide
alarmones called guanosine tetra- and penta-phosphate, (p)
ppGpp, and a transcriptional regulator DksA (4, 5). DksA is a
17 kDa protein with a coiled-coil N-terminal domain and
globular C-terminal domain consisting of a Zn2+-binding
motif with α-helix structures (3, 6). According to the structural
analysis, the Zn2+-binding motif of DksA consists of four
cysteine residues, which play a key role in sustaining the
folding of the C-terminal and coiled-coil regions of DksA (7).
Under nutrient starvation, a RelA enzyme is introduced to
tRNA for the purpose of sensing amino acid deficiency and
initiating the synthesis of (p)ppGpp via GTP and GDP con-
sumption (5, 8). Using (p)ppGpp, DksA binds to RNA poly-
merase (RNAP) for downstream transcriptional regulation,
such as the repression of rRNA gene transcription (3, 5, 9).
The mode of action regarding the interaction of DksA with
RNAP was uncovered in a series of studies using Escherichia
coli. In E. coli, the intracellular level of DksA remains constant
throughout the life cycle, unlike (p)ppGpp (10). The constant
level of DksA was initially considered to be crucial as it was
identified to suppress dnaKmutation with its chaperon activity
(3, 10). However, DksA was later revealed to be even more
significant as it serves as a transcriptional suppressor of rRNA
and ribosomal proteins in E. coli (3, 8). DksA directly binds to
RNAP and modulates RNAP activity by destabilizing the open
complex to prevent intermediate complexation by competition
for transcription initiation (3, 4, 11). A current model dem-
onstrates that DksA binding requires multiple interactions
with (i) rim helices of the β’-subunit, (ii) an active site of the β-
subunit, and (iii) a β-subunit site insertion 1 (β-SI1) in a sec-
ondary channel of RNAP (11).
DksA is also critically involved in regulating bacterial
pathogenesis in several pathogens (10, 12–15). In Vibrio
cholerae, DksA upregulated expression of fliA, encoding a
sigma factor that regulates its motility. Furthermore, uninter-
rupted production of cholera toxin and hemagglutinin prote-
ase required functional DksA (16). Likewise, in Salmonella,
DksA was found essential for the expression of motility,J. Biol. Chem. (2021) 296 100576 1
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that caused in vivo systemic infection (17). Moreover, DksA in
Salmonella controlled central metabolism to balance its redox
state, which in turn helped resist against oxidative stress
produced by antimicrobial phagocytes (18).
P. aeruginosa harbors five genes in its genome encoding
proteins belonging to the DksA superfamily, including two
that are highly homologous to the typical DksA in E. coli
(12, 19). Of these two DksA homologs, named DksA1 and
DksA2, DksA1 is structurally and functionally similar to E. coli
DksA. DksA2, on the other hand, was reported to only partially
replace DksA1 functions, as it lacks the typical Zn2+-binding
motif present in DksA (19). However, our recent study clearly
suggested that DksA1, not DksA2, plays a dominant role as a
suppressor of ribosomal gene expression (13). Importantly, a
ΔdksA2 mutant exhibited almost identical phenotypes with its
parental strain, PAO1, indicating that DksA2 can be dispens-
able. Beyond its traditional function, DksA1 was also identified
to regulate a wide range of phenotypes including quorum
sensing (QS)-related virulence, anaerobiosis, and motilities
(13). Based upon these findings, we hypothesized that DksA1
may be an efficient target for inhibiting P. aeruginosa infection.
In the present work, we screened a library of chemical
compounds (n = 6970) and identified two molecules that
effectively compromised DksA1 activity. PAO1 cells treated
with each candidate compound shared much of the charac-
teristics of the ΔdksA1 mutant, such as significant attenuation
of QS-mediated virulence and elevated antibiotic susceptibil-
ity. Furthermore, QS is considered as an antivirulence target to
control P. aeruginosa infection in Cystic Fibrosis (CF) (20).
Given that QS machinery has been a target for inhibition, our
results demonstrate that DksA1 can serve as a novel avenue to
achieve P. aeruginosa QS inhibition.
Results
Screening a library of chemical compounds for DksA1
inhibitors
To set up a screening scheme in a high-throughput manner,
we needed to find a phenotype of the ΔdksA1 mutant that can
be easily and reproducibly measured. In Salmonella, it was
reported that DksA modulates the redox balance in response
to oxidative stress, and the NADH level decreased when the
dksA gene is disrupted (18). We therefore examined whether
the phenotype observed in Salmonella is also detected in
P. aeruginosa. NADH levels are indirectly represented by the
conversion of tetrazolium salt to formazan (purple pigment),
which is mediated by a NADH-dependent reductase (21). In
accordance with what was observed in Salmonella, the
P. aeruginosa ΔdksA1 mutant produced a noticeably reduced
amount of formazan (Fig. S1A). Since the formazan assay can
easily be performed, we concluded that this assay can serve as
an efficient screening platform, minimizing the chance of
plate-to-plate variations. The library that we used was a
compound library consisting of a total of 6970 chemicals that
was provided by the Korean Chemical Bank. The screening
was conducted in two stages. To begin with, we screened the2 J. Biol. Chem. (2021) 296 100576entire library for the formazan assay to isolate candidate
compounds. Then, we compared phenotypes induced in PAO1
by each candidate compound with those of the ΔdksA1mutant
(Fig. S1B). Our goal was to isolate compounds that make
PAO1 behave like the ΔdksA1 mutant. In the first step, we
screened out a total of 178 chemical compounds including 25
compounds that robustly reduced formazan production and
153 mild reducers. In a repetitive formazan assay using these
153 mild reducers, we selected another set of 25 compounds
that exhibited relatively strong activities in reducing formazan
production. Consequently, a total of 50 compounds were
selected in the first stage (Fig. S1B).
It was previously reported that transcription of genes
encoding ribosomal proteins is highly activated in the ΔdksA1
mutant (12, 13). We postulated that these marked changes at
the transcriptional levels may allow us to verify the phenotypes
induced by candidate compounds. We therefore constructed a
reporter P. aeruginosa strain by chromosomally integrating an
rpsB gene promoter fused with lacZ ORF (PrpsB::lacZ). The
rpsB gene codes for 30S ribosomal protein S2. In our previous
work, we also reported that the production of elastase, a
dominant virulence determinant and an easily measurable
phenotype, is highly suppressed in the ΔdksA1 mutant (13).
Therefore, we also assessed elastase production as a second-
stage verification. By successive β-galactosidase and elastase
activity assays, we finally nominated a total of four chemicals,
55B05, 02G09, 86B09, and 45G08, as a set of final candidates.
We then monitored these two phenotypes in diverse cultiva-
tion conditions and at different time points to finally select
chemicals that yield consistent results. While reduced elastase
production and elevated rpsB transcription were observed at
4 h postinoculation by all four chemicals at a 50 μM con-
centration, the effects of 02G09 and 45G08 did not last for the
extended period of incubation (Fig. S2, A and B). At 8 h
postinoculation, the levels of elastase produced in 02G09-or
45G08-treated PAO1 were almost identical to that of PAO1
(Fig. S2B). Thus, 55B05 and 86B09 were finally selected as
DksA1 inhibitors, and we referred to these as Dkstatin-1
(DKST-1) and Dkstatin-2 (DKST-2).
Structure and specificity of Dkstatin-1 (DKST-1) and Dkstatin-2
(DKST-2)
The Korean Chemical Bank database provides the structures
of DKST-1 and DKST-2, and they were found to have distinct
chemical structures (Fig. 1, A and B). To further confirm that
Dkstatin (DKST) molecules act specifically against DksA1 ac-
tivity, formazan production and rpsB reporter expression were
measured in PAO1 and the ΔdksA1 mutant as well. Hereafter,
DKST-1 and -2 were used at 150 μM concentrations in all ex-
periments. Again, levels of formazan production in PAO1 were
noticeably reduced in the presence of DKST treatment (Fig. 1C).
It is of interest that formazan production in PAO1 treated with
150 μMDKST-1was even lower than that of theΔdksA1mutant.
On the other hand, levels of formazan production in the ΔdksA1
mutant were not further decreased by either DKST compound
(Fig. 1C). Likewise, DKST-1 andDKST-2 did not further increase
Figure 1. Effect of Dkstatin candidate compounds on P. aeruginosa. A and B, chemical structure of Dkstatin-1 (DKST-1) and Dkstatin-2 (DKST-2). C,
relative formazan production of PAO1 and ΔdksA1 mutant grown in LB with 150 μM DKST-1 and DKST-2 for 4 h. The values of mean ± S.D. are presented
(n = 3). D, relative rpsB expression of PAO1 PrpsB::lacZ and ΔdksA1 PrpsB::lacZ strains incubated in LB with 150 μM DKST-1 and DKST-2 for 8 h. The rpsB gene
expression is represented as β-galactosidase activity. The values of mean ± S.D. are presented (n = 3).
Dkstatin-induced virulence attenuation of P. aeruginosathe rpsB gene transcription in the ΔdksA1 mutant (Fig. 1D). As
DKST-1 and DKST-2 were identified to inhibit DksA1 activity,
no apparent effects of DKSTs were present in a strain devoid of
dksA1 gene. These results suggest that Dkstatin compounds
selectively inhibit DksA1 activity.
DKST compounds interrupt QS-mediated virulence in
P. aeruginosa
DksA1 plays versatile roles at the transcriptional level
affecting various phenotypes (13). Therefore, DKST molecules
inhibiting the activity of DksA1 may induce diverse physio-
logical changes in P. aeruginosa. To identify whether DKSTs
affect the growth of PAO1, we conducted growth curve ex-
periments of PAO1 in the presence of 150 μM of DKSTs.
Control growth curves were obtained by adding equal volume
of DMSO used as a solvent. In comparison with PAO1 and
ΔdksA1 mutant, PAO1 growth never changed upon DKST-1
supplementation (Fig. 2A). To our surprise, a noticeable in-
crease CFU/ml values in PAO1 growth was repeatedly
observed at exponential phase when treated with DKST-2
(Fig. 2A). When CFU was enumerated 8 h postinoculation,
no obvious growth enhancement was observed (Fig. 2B).Together, these two sets of results indicate that DKST-1 and -2
at least do not downregulate bacterial growth and viability.
At a concentration of 150 μM, DKST-2 suppressed elastase
production to a more significant degree (Fig. 2C). Under DKST-
2-treated conditions, the level of elastase production was less
than 40% of what control PAO1 cells produced. Elastase pro-
duction in PAO1 treated with 150 μM DKST-1 was approxi-
mately 65% of the control level. Along with elastase, pyocyanin is
another crucial virulence determinant whose production is also
controlled by QS in P. aeruginosa (2, 22, 23). When we measured
the pyocyanin production, a marked reduction was observed in
DKST-treated PAO1 (Fig. 2D). Interestingly, the degree of
reduction by either DKST molecule in PAO1 was comparable to
that induced by the dksA1 gene deletion (Fig. 2D). The loss of
pyocyanin production was clearly represented in the image of
culture supernatants shown in Figure 2E.
In P. aeruginosa, QS is operated by small organic molecules,
termed autoinducers (24). Since major QS-mediated pheno-
types were suppressed in DKST-treated PAO1 and in the
ΔdksA1 mutant, we monitored how many autoinducers were
produced in response to the DKST treatment. Two homo-
serine lactone (HSL) autoinducers, 3-oxo-C12-HSL andJ. Biol. Chem. (2021) 296 100576 3
Figure 2. Effects of Dkstatin-1 and Dkstatin-2 on bacterial growth and virulence. A, growth curves of PAO1 and ΔdksA1 mutant in plain LB and LB
supplemented with 150 μM of Dkstain-1 (DKST-1) or Dkstatin-2 (DKST-2). Aliquots of bacterial cultures (n = 3) were withdrawn every hour to measure CFU/
ml values. *p < 0.05 versus growth of PAO1. B, cell viability of PAO1 incubated with DKST-1 and DKST-2. C, relative elastase activity of tested strains. Elastase
activity was measured as described in the Experimental procedure and was normalized with that of PAO1. The values of mean ± S.D. are presented (n = 4).
*p < 0.05 versus that produced of PAO1. **p < 0.05 versus that produced of PAO1-treated with DKST-1. D, pyocyanin production in each condition was
quantified and normalized with that of PAO1. The values of mean ± S.D. are presented (n = 3). *p < 0.05 versus that produced of PAO1. E, visual comparison
of bacterial culture supernatants. Loss of pigment was clearly observed in PAO1 and both Dkstatin compounds. Statistical analysis in all experiments was
carried out for paired Student’s t-test in comparison of PAO1 as control group.
Dkstatin-induced virulence attenuation of P. aeruginosaC4-HSL, were semiquantitatively measured as described in the
Methods section. Based on our quantification, levels of 3-oxo-
C12-HSL produced in either DKST-1 or DKST-2-treated
PAO1 cells were almost identical to that in the ΔdksA1
mutant (Fig. 3A). Similarly, levels of C4-HSL produced upon
treatment with either DKST were noticeably decreased to 53%
and 63% of what was detected in the control group, respec-
tively (Fig. 3B).
When DKST-treated PAO1 cells were cotreated with
extraneous C4-HSL and 3-oxo-C12-HSL, elastase production
was restored (Fig. S3). Elastase production was almost
completely recovered following 4 h autoinducer complemen-
tation, while the complementation effects diminished there-
after (Fig. S3). These results demonstrate that the LasI-R and
RhlI-R QS circuits can be substantially impaired by two
DKSTs, with the LasI-R system being suppressed almost to the
degree of the ΔdksA1 mutant. Furthermore, our results indi-
cate that DKST-induced virulence attenuation occurred at the
level of the HSL-based autoinducer production.
Anaerobic respiration is affected by DKSTs
The transcription of genes involved in denitrification or
anaerobic respiration requires DksA1 activity (13). We4 J. Biol. Chem. (2021) 296 100576therefore examined whether the DKST compounds also
have an impact on anaerobic respiratory growth of
P. aeruginosa. We tested bacterial growth using NO3
− as an
alternative electron acceptor. When cells were grown
anaerobically with 25 mM NO3
−, PAO1 strains reached an
average OD600 value of 1.6 in 24 h (Fig. 4A). In contrast,
final OD600 values plateaued at 1.24 in the ΔdksA1 mutant
under the same conditions. Under the DKST-1 supple-
mented growth conditions, PAO1 grew up to OD600 values
of 1.18, similar to the growth of a ΔdksA1 mutant. Like-
wise, average OD600 values were 1.27 in the presence of
DKST-2 (Fig. 4A). Interestingly, the growth stimulating ef-
fect of DKST-2 (Fig. 2A) observed during aerobic growth
was not detected under anaerobic respiration. In a CFU
counting assay, we observed that the addition of DKST-2
resulted in a similar outcome as the ΔdksA1 mutant
(Fig. 4B). Around tenfold decreases in viable cell numbers
were observed at the end of the growth experiments both in
PAO1 treated with DKST-2 and in the ΔdksA1 mutant,
whereas a significant difference in cell numbers was not
detected when DKST-1 was supplemented. Together, these
results illustrate that DKST compounds are involved in
suppression of major anaerobic respiration pathways in
Figure 3. Measurement of 3-oxo-C12-HSL and C4-HSL produced when
supplemented with Dkstatin compounds. A, relative levels of 3-oxo-C12-
HSL (C12-HSL) were measured using an E. coli reporter strain harboring a
pKDT17 plasmid. Concentrations of C12-HSL are represented as β-galacto-
sidase activity. The values of mean ± S.D. are presented (n = 3). B, relative
levels of N-butyryl-homoserine lactone (C4-HSL) were monitored by
measuring the violacein production from the biosensor strain C. violaceum
CV026. Violacein production was measured at 590 nm absorbance and was
normalized to the OD600 values of CV026. In total, 150 μM Dkstain-1 (DKST-
1) and DKST-2 (DKST-2) were supplemented in all experiments.
Dkstatin-induced virulence attenuation of P. aeruginosaP. aeruginosa, although the degree of impact varies between
the two DKSTs.
DKST-1 and DKST-2 increase antibiotic susceptibility
P. aeruginosa is notorious for its antibiotic resistance (1). As
an opportunistic pathogen, it has also acquired resistance to
multiple drugs (1, 25). Our previous data showed that the
ΔdksA1 mutant became hypersusceptible to gentamycin or
tetracycline at sub-MIC conditions (13). In contrast, the
mutant was not more susceptible to β-lactam antibiotics, such
as ampicillin and carbenicillin, than PAO1 (13). To examine
whether the DKST treatment would lead to the interruption ofFigure 4. Effects of Dkstatin-1 and Dkstatin-2 on anaerobic respiration. A,
150 μM Dkstain-1 (DKST-1) and Dkstatin-2 (DKST-2). In total, 25 mM NO3− wa
aliquots (n = 2) were measured every 2 h. B, the cell viability of anaerobically g
Bacterial cultures grown anaerobically for 24 h in LB supplemented with 25 mM
on an LB agar plate. The plates were incubated in anaerobic conditions at 37DksA1 activity resulting in increased antibiotic susceptibility,
we tested imipenem (Imp), gentamycin (GM), tetracycline
(TC), kanamycin (KM), streptomycin (SM), and tobramycin
(TB). DKSTs failed to increase PAO1 susceptibility in response
to the treatment with Imp at a 2.5 μg/ml concentration
(Fig. 5A). Supplementation of DKST-1 or DKST-2 both at
150 μM concentration significantly reduced cell viability when
PAO1 cells were incubated with 2.5 μg/ml of GM (Fig. 5B).
Here, a more than tenfold decrease in cell viability was
detected in the presence of either DKST. Interestingly,
increased susceptibility by DKST was also observed during
incubation with other aminoglycoside antibiotics such as KM
(Fig. 5D), SM (Fig. 5E) or TB (Fig. 5F). In the presence of
DKST, viable cell numbers of KM-treated PAO1 cells
decreased around tenfold when compared with the DMSO-
treated PAO1 control (Fig. 5D). Severe loss of viability was
observed in PAO1 cells being cotreated with SM and DKST as
well (Fig. 5E). We also observed that DKST treatment
increased PAO1’s susceptibility to 8 μg/ml of TC, an antibiotic
that also inhibits protein synthesis machinery (Fig. 5C). These
results indicate that DKSTs specifically increase bacterial
susceptibilities to antibiotics that specifically target protein
biosynthesis in P. aeruginosa.
DKSTs interfere with DksA1’s interaction with RNA polymerase
Action of DksA1 is dependent on its interaction with RNA
polymerase (RNAP). It was reported that DksA1 binds to the β
subunit of RNAP in E. coli (11). We hypothesized that DKSTs
may work by one of two possible scenarios. First, DKSTs may
inhibit the production of DksA1 in P. aeruginosa. Second,
DKSTs may interfere with DksA1’s binding to RNAP. To
precisely understand how DKSTs inhibit DksA1 activity, we
constructed a modified PAO1 strain, where the 3’-end of the
dksA1 gene is fused with the nucleotide sequences coding for
the 3XFLAG tag. In this strain, DksA1 is translated as a fusion
protein with the 3XFLAG tag at its C-terminus. To begin with,
we tested whether DKST compounds affect production of
DksA1 through western blotting. As a result, western blottinggrowth curves of PAO1 and ΔdksA1 mutant in LB and LB supplemented with
s added as an alternative electron receptor. OD values of bacterial culture
rown ΔdksA1 mutant and PAO1incubated with 150 μM DKST-1 and DKST-2.
NO3− were serially diluted. In total, 10 μl of each diluent was spot inoculated
C for 24 h.
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Figure 5. Effects of Dkstatin-1 and Dkstatin-2 on antibiotic susceptibility. CFU counting of PAO1 incubated with Dkstatin-1 (DKST-1) and Dkstatin-2
(DKST-2) when supplemented with antibiotics; (A) 2.5 μg/ml of imipenem, (B) 2.5 μg/ml of gentamicin, (C) 8 μg/ml of tetracycline, (D) 25 μg/ml of
kanamycin, (E) 12.5 μg/ml of streptomycin, and (F) 1 μg/ml of tobramycin. ΔdksA1 mutant was incubated in LB under same condition to PAO1. All ex-
periments were performed as three independent replicates.
Dkstatin-induced virulence attenuation of P. aeruginosausing an anti-FLAG antibody indicates that the level of DksA1
production was never changed by the treatment with either
DKST (Fig. 6A). The DksA1-specific band was not detected in
the sample prepared from the original PAO1 strain (Fig. 6A,
far-left lane). Next, we conducted a co-immunoprecipitation
assay using a magnetic bead (on which an anti-FLAG anti-
body is immobilized) to examine the effect of DKST treatment
on the interaction of DksA1 with RNAP. When precipitated
fractions in each preparation were probed with an anti-RpoB
antibody, the RpoB band intensity was markedly reduced in
both DKST-treated samples, with DKST-2 being superior to
DKST-1 in conferring such effects (Fig. 6B). Taken together,
these results demonstrate that DKSTs likely act as inhibitors at
the posttranslational level by interfering with DksA1’s binding
to RNAP.
DKST-1 and DKST-2 induced distinct changes in transcriptome
profiles of PAO1
Although two DKSTs invariably suppressed the activity of
DksA1, inducing similar phenotypic changes, the chemical
structures of the two molecules are quite different (Fig. 1, A
and B). To better understand the effects of DKST6 J. Biol. Chem. (2021) 296 100576treatment, we compared transcriptome landscapes of PAO1
grown without or with either DKST. A global view of the
entire transcriptome uncovered the substantial differences
between cells treated with DKST-1 or DKST-2 (Fig. S4A).
This finding was also supported by our PCA plot, which
indicates that either treatment induced divergent changes
(Fig. S4B). As far as the number of affected genes was
concerned, the effect of DKST-1 treatment appeared
stronger than that exerted by DKST-2 (Fig. 7A). Again,
among those genes whose expression was substantially
altered, only a small portion was simultaneously affected by
either compound.
At first, we confirmed that the transcription of genes
encoding ribosomal proteins was upregulated during the
treatment with DKST-1 or DKST-2, with the latter exhibiting
more significant effects (Fig. 7B). These results further verified
that two compounds can in fact effectively compromise the
activity of DksA1. We then examined the effects of DKST
treatment on the expression of genes involved in QS and QS-
mediated virulence factor production. As shown in Figure 7C,
transcription of genes encoding autoinducer synthases and
autoinducer-binding receptors was suppressed in DKST-
Figure 6. Intracellular production of DksA1 in response to Dkstatin
treatment and effects of Dkstatin treatment on binding of DksA1 with
RNA polymerase β subunit. A, original strain of PAO1(first lane) and PAO1
harboring a dksA1::FLAG translational fusion construct (following lane) were
grown in LB in the presence of either 150 μM Dkstatin-1 (DKST-1) or
Dkstatin-2 (DKST-2) for 8 h. Intracellular fractions were subjected to western
blot with an anti-FLAG antibody. As a control, strains were treated with
equal volumes of DMSO (Con). Samples at equal protein concentrations
were loaded into 12% SDS-PAGE gel. B, RpoB western blot conducted with
anti-RpoB antibody to determine RpoB of P. aeruginosa (upper panel). RpoB
and DksA1 western blot conducted with RpoB antibody and anti-FLAG
antibody after immunoprecipitation using magnetic beads. RpoB western
blot shown with anti-RpoB antibody from immunoprecipitation conducted
by magnetic beads coated with anti-FLAG antibody (middle panel). Relative
RpoB band intensities were indicated. DksA1-FLAG western blot conducted
with anti-FLAG antibody using precipitates produced by magnetic beads
(bottom panel). A PAO1 strain with dksA1::FLAG translational fusion
construct was grown for 8 h in the presence of 150 μM Dkstatin-1 (DKST-1),
Dkstatin-2 (DKST-2) or an equal volume of DMSO (Con). Each intracellular
extract was incubated with an equal volume of magnetic beads conjugated
with an anti-FLAG antibody and was precipitated. Resuspended precipitates
were loaded onto SDS-PAGE gel for western blot with the anti-FLAG anti-
body and the anti-RpoB antibody. IP, immunoprecipitation; WB, western
blot.
Dkstatin-induced virulence attenuation of P. aeruginosatreated PAO1 cells. Among these, pqsABCDE and phnAB
genes that constitute the PQS biosynthesis cluster were most
affected. Importantly, the expression of virulence-associated
genes was remarkably decreased, especially in response to
the treatment with DKST-1 (Fig. 7D). Genes coding for elas-
tase (lasB), alkaline protease (aprADEF), and rhamnolipid
(rhlAB) were considerably downregulated. Similarly, tran-
scription of genes involved in phenazines production
(phzA1G1 and phzA2G2) and siderophore biosynthesis
(pchAG and pchR) were also suppressed in DKST-treated
cells (Fig. 7D). These results clearly suggest that DKST-
induced virulence suppression is due to the effects man-
ifested at the transcriptional level. In addition, gene expression
for the production of hydrogen cyanide (hcnAC) and type II
secretion machinery (tadBD) was less active in the presence
of DKSTs.In our previous data shown in Figure 4A, DKST treatments
suppressed anaerobic respiratory growth of PAO1. In
P. aeruginosa, anaerobic respiration is mediated by a series of
reductions from nitrate (NO3
−) to N2 with nitrite (NO2
−), ni-
tric oxide (NO), and nitrous oxide (N2O) as intermediates (26).
The expression of genes involved in the activity of nitrate
reductase (NAR) that mediates the first step of anaerobic
denitrification was slightly increased in the presence of DKSTs.
In contrast, DKSTs significantly suppressed the expressions of
gene clusters (nirSMCFLGHJND and norCBD) encoding ni-
trite reductase (NIR) and nitric oxide reductase (NOR) that
catalyze the next steps of denitrification to produce nitrous
oxide (27). Similarly, the expression of nosRZDFYL cluster
encoding nitrous oxide reductase also invariably decreased
during DKST treatment (Fig. 7E).
Our data shown in Figure 2A indicate that DKST-2 stimu-
lated PAO1 growth in LB. To address this unexpected phe-
nomenon, our interest also reached the genes involved in
energy metabolism such as systems for electron transport and
ATP biosynthesis. The two gene clusters, ccoN1O1Q1P1 and
ccoN2O2Q2P2, encode subunits of cbb3-type cytochrome
oxidase, a critical enzyme for aerobic respiration (28, 29).
Compared with the control PAO1 cells, transcription of these
two gene clusters was remarkably increased in PAO1 cells
treated with DKST-2 (Fig. 7F). Furthermore, a large operon
atpABCDEFGHI encoding ATP synthase complex was more
actively transcribed in the same cells (Fig. 7G). These results
provided insight into how DKST-2 treatment promoted the
PAO1 aerobic growth. Collectively, our RNASeq analysis
revealed that two DKST compounds induced transcriptional
changes, which were well reflected at the phenotypic level. In
addition, we further confirmed that the wild-type PAO1 cells
subjected to DKST treatment behaved like a ΔdksA1 mutant.
DKST-1 and DKST-2 attenuated virulence of P. aeruginosa
in vivo
As the production of virulence factors decreased by DKST
treatment, we next tested whether DKST-induced virulence
attenuation is still valid in vivo using 8-week-old C57BL/6
female mice. All mice were intranasally infected with freshly
harvested PAO1 cells (106 CFU). Mice infected with PAO1
(n = 3) perished within 36 h (Fig. 8A, green line). On the other
hand, when either DKST was supplemented together with
PAO1 infection (n = 4), mice exhibited significantly increased
survival rates and survived even after at 48 h postinfection
(Fig. 8A). In a separate set of experiments, we also examined
the effect of DKST treatment on PAO1 proliferation inside the
host airway. In this case, mice were infected with 3 × 106
PAO1 cells. At 12 h postinfection, the average bacterial load in
the lungs of the control group was 5.2 × 105 CFU. Impor-
tantly, the bacterial load was significantly decreased to 4.7 ×
104 CFU, when treated with DKST-1. In contrast, the bacterial
count was not decreased by DKST-2 (Fig. 8B). This finding
correlates well with our RNASeq results, in that DKST-1
treatment strongly suppressed the transcription of virulence-
associated genes (Fig. 7D). We also assessed the effects ofJ. Biol. Chem. (2021) 296 100576 7
Figure 7. Comparison of effects of Dkstatin-1 and Dkstatin-2 on gene expression. A, Venn diagram for number of genes affected by Dkstatin-1 (DKST-1)
or Dkstatin-2 (DKST-2) treatment. Expression fold range was separated as two to fourfold and over fourfold. B, expression of 50S and 30S ribosomal protein
encoding genes. DKST-2 was more effective to increase expression of those genes. C, expression of genes participated in three major QS circuits was
downregulated in the presence of both DKST-1 and DKST-2. D, transcription of genes for virulence factors. Phenazine biosynthesis clusters (phzA1G1 and
phzA2G2) were remarkably downregulated for either DKST. E, expression of genes involved in all steps of denitrification. Gene clusters (nirSMCFLGHJND
and norCBD) encoding nitrite reductase (NIR) and nitric oxide reductase (NOR) were invariably downregulated in both DKST-1 and DKST-2. F, expression of
genes categorized as electro transfer. The two cbb3-type cytochrome c oxidase encoding gene set (ccoN1P1 and ccoN2P2) was upregulated by DKST-2.
G, expression of ATP synthase complex encoding gene operon. All total RNAs were harvested as biological duplicates.
Dkstatin-induced virulence attenuation of P. aeruginosaDKST treatment by visualizing lung tissues. Intranasal infec-
tion of PAO1 led to infiltration of immune cells and a
reduction of alveolar spaces, which are indicators of severe
airway infections (Fig. 8F). When PAO1-infected mice were
treated with DKSTs, inflammatory symptoms substantially
decreased compared with those observed in the control
infection group (Fig. 8, G and H versus Fig. 8F). The presence
of lung damage was not obvious when the mice were treated
with DKST-1 (Fig. 8D) or DKST-2 (Fig. 8E). Together, these
results suggested that DKST-1 and DKST-2 are not toxic to
the murine host and thereby these two molecules may have
potential to be developed as anti-Pseudomonas agents for
human patients.
Discussion
Bacterial cells developed numerous systems to handle
environmental stresses. SR is one of those systems, and it is
activated under the stress of nutrient starvation. Active SR
requires DksA1, a protein conserved across bacterial species.
Besides this well-recognized function, previous studies from
our lab revealed that DksA1 acts as a major transcriptional
regulator for QS-mediated virulence expression in
P. aeruginosa (13). In addition, DksA1 is also required for
uninterrupted expression of genes encoding proteins for bio-
film formation, motility, anaerobic respiration through deni-
trification, and polyamine metabolism (13). As DksA1
participates in regulating a wide range of phenotypes,8 J. Biol. Chem. (2021) 296 100576including virulence in P. aeruginosa, we postulated that DksA1
is an effective drug target, the inhibition of which may result in
virulence attenuation, eventually leading to control of recal-
citrant P. aeruginosa infections. The success of our compound
library screen is attributed to the following aspects. First, the
use of formazan production as a surrogate marker of
DksA1activity provided a system that allowed us to screen
6970 compounds with minimal error. Second, the reporter
strain, in which the transcriptional fusion of PrpsB::lacZ has
been inserted as a single copy at a nonfunctional region of
PAO1 genome (30), provided a reliable method for the second-
stage verification. This was critical because reduced produc-
tion of formazan can result from other metabolic alterations.
Lastly, DKST-1 and DKST-2 were found to be commercially
available for purchase, enabling us to test the effects of these
two final candidates at higher concentrations with no limited
supply. Considering that the initial screening could only be
performed with compounds at 50 μM concentration, the
availability of DKSTs made this study more feasible.
DKST-1 and DKST-2 have quite different chemical struc-
tures. Both compounds, however, induced specific outcomes
mediated by loss of DksA1 activity, ranging from (i) increased
rpsB expression, (ii) reduced elastase production, (iii) reduced
pyocyanin production, (iv) suppressed autoinducer produc-
tion, and (v) defective anaerobic respiration. These results
display the common features of two compounds affecting
DksA1 activity. DksA1 possesses a Zn2+-binding motif
Figure 8. In vivo virulence analyses of Dkstatin-1 and Dkstatin-2. A, survival curves of mice infected with PAO1 (green line) and PAO1 combined with
Dkstatin-1 (DKST-1, red line) or Dkstatin-2 (DKST-2, orange line). The infection dose was 106 cells per mouse. *p < 0.05 versus survival rate of PAO1-infected
mice. Four mice were used in each group. B, bacterial CFU values counted from whole dissected lungs. The initial dose was 3 × 106 cells per mouse of PAO1
or PAO1 combined with 150 μM of DKST-1 or DKST-2. *p < 0.05 versus CFU of the PAO1-infected mice. C, H&E stained histological visualizations of lung
tissues from mice intranasally administrated DMSO only, (D) 150 μM of DKST-1 and (E) DKST-2. F, H&E stained lung tissues of mice infected with PAO1
combined with DMSO, (G) PAO1 combined with 150 μM of DKST-1 and (H) DKST-2. 200 μm scale bar was indicated as black bar at lower right.
Dkstatin-induced virulence attenuation of P. aeruginosa(CXXC-N17-CXXC) consisting of four cysteine residues at its
C-terminus, and this motif is critical for its structure and
function. Of note, the cysteine thiol group is highly susceptible
to oxidation by electrophilic molecules (3, 19, 31). Regardless
of the structural differences, both compounds harbor reactive
groups, such as fluorine (32) and butanone (33, 34). Thus, it is
reasonable to hypothesize that oxidizing groups in DKSTs may
affect the DksA1 structure, which in turn leads to interference
with DksA1 binding to a subunit of RNAP. Future work should
focus on understanding DKST-induced structural modifica-
tion of DksA1 and its downstream consequences. To this end,
it is necessary to explore other chemicals harboring diverse
oxidizing moieties as well.
Based on Figure 2A, DKST-2 stimulated bacterial growth.
While the enhanced bacterial growth was not fully reflected in
the viable cell counting assay, we became interested in this
unexpected result. It is counterintuitive that a compound that
has potential to be developed as an antiinfective agent also
stimulates bacterial growth. However, it is also noteworthy
that actively replicating cells are well known to be more sus-
ceptible to antibiotic treatment (35). In line with this notion,
P. aeruginosa invaders might be more exposed to host im-
munity when they multiply at a faster rate. In contrast to theaerobic culture, DKST-2 strongly suppressed anaerobic res-
piratory growth of PAO1 (Fig. 4B). Earlier studies clearly
suggest that P. aeruginosa may benefit from anaerobiosis
during chronic airway infection (26). It will be important to
further clarify whether DKST-2 specifically suppresses chronic
airway infection by P. aeruginosa.
QS, a cell density-dependent gene regulatory system, is
crucial for the production of virulence determinants in
P. aeruginosa (23). Therefore, P. aeruginosa QS has been
extensively studied as a therapeutic target for virulence
attenuation (1, 23, 36). To date, strategies for QS inhibition
include receptor inactivation (37), inhibition of signal synthe-
sis, use of autoinducer analogues (38), signal degradation
(39, 40), and use in combination with antibiotics (38). Flavo-
noids bind QS receptor, LasR, and RhlR, to reduce virulence
factor production (37). N-decanoyl-L-homoserine benzyl ester,
a structural analogue of 3-oxo-C12-HSL, downregulates elas-
tase production, swarming motility, and biofilm formation
without growth defects (22). This QS-inhibitor also synergis-
tically interacts with gentamicin and tobramycin (38). Another
QS inhibitor, meta-bromo-thiolactone, affects LasR and RhlR
activity to decrease pyocyanin production and biofilm forma-
tion in P. aeruginosa PA14 strain (41). In a screen with aJ. Biol. Chem. (2021) 296 100576 9
Dkstatin-induced virulence attenuation of P. aeruginosasynthetic N-acyl-homoserine lactone (A-HSL) library, various
HSL derivatives were found to antagonize the activity of LasR
and LuxR in P. aeruginosa and Vibrio fischeri (42). Likewise, a
couple of autoinducer analogues were found to antagonize
TraR, a QS-related LuxR homologue in Agrobacterium tume-
faciens (42). Of note, the previously mentioned examples show
findings from studies designed to uncover molecules that
directly inhibit or antagonize at various levels of the
P. aeruginosa QS machinery. In the present study, however, we
discovered molecules that target DksA1, whose involvement in
P. aeruginosa QS is relatively a new subject. We argue that
DksA1 should be an avenue for future exploration in the
context of development of P. aeruginosa QS inhibitors with a
focus on its molecular nature and its impact on virulence gene
regulation.
Our RNASeq analysis clearly suggested that the two DKSTs
induced distinct changes in the genome-wide transcription
pattern. When differentially expressed genes (DEGs) were
categorized based on the gene ontology (GO) term, a larger
number of GO terms were retrieved in DKST-2-treated group
(11 terms) than in the DKST-1-treated group (9 terms). Of
particular interest, the most significantly presented GO term
in the DKST-2 treated group was “translation” with all 23
upregulated genes (Fig. S5B). Along with this GO term, several
other functional categories, such as ribosomal assembly and
energy metabolism, were also identified with genes of
enhanced transcription. Given that these changes resemble the
characteristics of the ΔdksA1 mutant, it is likely that DKST-2,
as compared with DKST-1, is more potent in inhibiting DksA1
activity. Consistent with this idea, binding of DksA1::FLAG
and RpoB was hampered to a greater degree by DKST-2
(Fig. 6B). In the DKST-1-treated group, on the other hand,
the “phenazines biosynthesis process” was most significantly
presented (Fig. S5A). In addition, 10 out of 12 genes in the
“pathogenesis” category and all genes in the “secretion,” “type
VI secretion system,” and “chemotaxis” terms were down-
regulated in DKST-1-treated cells (Fig. S5A), suggesting that
DKST-1 may be more directly engaged in attenuating
P. aeruginosa virulence. Collectively, these additional bio-
informatic analyses further support the notion that DKST-1
and DKST-2 may operate in different modes of action even
though these two molecules were identified as DksA1
inhibitors.
Antibiotic resistance in many human pathogens (including
P. aeruginosa) has already become a global healthcare prob-
lem. Against the opportunistic features of P. aeruginosa, we
need to come up with antibiotic-independent infection control
strategies. Interventions that could achieve virulence attenua-
tion without imposing selective pressure have been actively
attempted (36). DKSTs identified in the present study signifi-
cantly downregulated P. aeruginosa virulence by suppressing
QS mechanisms. Moreover, DKSTs induced elevated anti-
biotic efficacy at sub-MIC conditions, especially for antibiotics
that inactivate protein synthesis. As DksA1 suppresses tran-
scription of genes encoding rRNA and ribosomal proteins,
macromolecular ribosomes are readily accumulated when
DksA1 is inactivated. Therefore, it is anticipated that10 J. Biol. Chem. (2021) 296 100576ribosome-targeting antibiotics are more active under such
conditions.
In summary, DksA1 in P. aeruginosa positively regulates its
virulence by activating QS. This finding led us to hypothesize
that inhibiting DksA1 would result in virulence attenuation of
the pathogenic P. aeruginosa. We identified two molecules that
effectively suppressed DksA1 function from a large-scale
compound library screen. These two compounds suppressed
P. aeruginosa virulence and therefore protected a murine host
from lethal infection with P. aeruginosa. Moreover, the com-
pounds also rendered P. aeruginosa more susceptible to anti-
biotics. Our results demonstrate that fatal P. aeruginosa
infections can be controlled by inhibiting DksA1. Collectively,
DKSTs are attractive drug candidates in establishing future
plans to cope with antibiotic-resistant infections. We antici-
pate that future investigations will propose detailed molecular
mechanisms of DKSTs and apply these in human trials.
Experimental procedure
Ethics statement
All animal studies were performed in compliance with the
guidelines provided by the Department of Animal Resources of
Yonsei Biomedical Research Institute. The Committee on the
Ethics of Animal Experiments at the Yonsei University College
of Medicine approved this study (permit number 2018-0246).
Bacterial strains, culture conditions, and chemicals
Bacterial species and plasmids used in this study are listed in
Table S1. A laboratory strain of P. aeruginosa, PAO1, was used
as a wild-type strain. Unless otherwise specified, bacterial
strains were cultivated in Luria-Bertani media (LB; 1% (w/v)
tryptone, 0.5% (w/v) yeast extract, and 1% (w/v) sodium
chloride) at 37 C. Standard cloning procedures that involved
allelic exchange were performed. When necessary, ampicillin
(100 μg/ml), carbenicillin (100 μg/ml), gentamycin (60 μg/ml),
or irgasan (25 μg/ml) were used for clonal selection. DNA
sequences encoding 3XFLAG tag were amplified and ligated to
the downstream of the multicloning site (MCS) of the pBAD24
plasmid, resulting in the construction of pBAD24F. Then, the
dksA1 gene was cloned into the MCS of pBAD24F. The
resulting dksA1::FLAG sequence was amplified and ligated into
pCVD442 (35) for chromosomal integration. The promoter
region of rpsB gene was fused with the promoterless lacZ open
reading frame (PrpsB::lacZ), and the resulting construct was
cloned into the plasmid, pUC18-mini-Tn7t-Gm-lacZ (30) for
chromosomal integration. Dkstatin-1 (4,4’-(4,4’-biphenyldiyl
disulfonyl)di(2-butanone)) and Dkstatin-2 (N-ethyl-3-[(3-
fluorophenyl)methoxy]-N-[(1-methyl-1H-imidazol-5-yl)
methyl]aniline) were purchased from Chembridge Corp and
Asinex Inc, respectively.
Screening of chemical compounds
Screening of chemical compounds was performed in two
phases. Using a chemical compound library consisting of
6970 chemicals provided by the Korea Chemical Bank
(https://chembank.org/), we first screened for chemical
Dkstatin-induced virulence attenuation of P. aeruginosacompounds that inhibit DksA1 activity. The total library was
tenfold diluted with DMSO to increase the volume. A 100-
fold diluted overnight culture of P. aeruginosa PAO1 and
the ΔdksA1 mutant were then incubated in fresh media for an
additional 4 h to activate the cells. The obtained OD600 values
of these strains were adjusted to 1.0. Then, 120 μl of the
adjusted culture was inoculated in 96-well plates that contain
50 μM of chemical compounds, and these were incubated at
37 C for 1 h to examine formazan production. After incu-
bation, 0.05 mg/ml of thiazolyl blue tetrazolium bromide
(Sigma-Aldrich) was distributed into each well of the test
plates, and they were incubated for an additional 30 min at 37
C. The formazan production was measured at a 550 nm
wavelength after dissolving it in DMSO. The top 50 com-
pounds that presented the lowest levels of formazan pro-
duction during the first screening phase were then subjected
to a subsequent screening. In the following screening phase, a
reporter strain PAO1 PrpsB::lacZ was diluted 100-fold and
added to 1.5 ml of LB supplemented with 50 μM of each of
the 50 compounds. The sample was then incubated for 4 h at
37 C with shaking. rpsB expression of the reporter strain was
represented in Miller Units and was measured as described
previously (13). Based on the rpsB expression, the top 20
compounds among the 50 previously screened compounds
were selected. To further narrow down the candidate com-
pounds from the 20 selected compounds, the reporter strain
was incubated in 3 ml of LB with the addition of 50 μM of
each of the 20 compounds for 4 h with shaking. Measurement
of the elastase activity and quantification of rpsB expression
allowed us to come down to the four most efficacious com-
pounds: 55B05, 02G09, 86B09, and 45G08. Then, 50 μM of
four these compounds was tested again by measuring elastase
activity and rpsB expression of reporter strain incubated in
5 ml of LB for 4 to 8 h at 37 C. 55B06 and 86B09 were
specifically chosen as they showed sustained effects on elas-
tase activity and rpsB expression. Then, 150 μM of 55B05 and
86B09 were each added to PAO1 and ΔdksA1 mutant incu-
bated in 5 ml of LB medium for 4 h at 37 C to measure
formazan production.
Elastase and pyocyanin assay
Elastase activity was measured as previously described
(43). First, 500 μl of supernatant from cultures incubated
with 50 μM or 150 μM of the compounds for 4 h or 8 h was
mixed with 1 ml of 30 mM Tris-HCl buffer containing
10 mg/ml of Elastin-Congo Red (Sigma-Aldrich). The
mixture was then incubated with shaking at 37 C for 1 to
2 h. After the incubation, 1 ml of the mixture was trans-
ferred into a micro tube, which was centrifuged at
13,000 rpm for 1 min. In the pyocyanin assay, 5 ml of su-
pernatants from the cultures incubated for 8 h with 150 μM
Dkstatin compounds was harvested by centrifugation at
3000 rpm for 20 min. They were then filter-sterilized (0.2-
μm pore size, Sartorius Minisart Sterile EO filters; Sartorius
AG). Then, 4 ml of chloroform was added to 8 ml of the
supernatants in a 15 ml conical tube, and the mixture washomogenized. After homogenization, the tubes were
centrifuged at 3000 rpm for 10 min to collect the blue layer
fraction submerged to the bottom of the tube. Then, 4 ml of
the collected blue layer was transferred into a new tube, and
2 ml of 0.2 N HCl was added to produce a red-colored
mixture. For the assay, 1 ml of the mixture was then
transferred into a microtube for centrifugation at
13,000 rpm for 1 min. Absorbance at 520 nm (OD520) was
then measured for the samples.
Autoinducer assay
In HSL measurements, both C4-HSL and 3-oxo-C12-HSL
were extracted from 5 ml of culture supernatants using the
equivalent volume of acidified ethyl acetate. The extractions
were repeated twice to fully collect the ethyl acetate frac-
tion. N2 gas was used to evaporate and dry out the collected
ethyl acetate fraction. The residues were dissolved in 250 μl
of HPLC grade ethyl acetate to obtain 20-fold concentrated
extracts. Measurement of 3-oxo-C12-HSL was performed
using an E. coli strain harboring reporter plasmid pKDT17
containing a copy of lasR-lacZ transcriptional fusion (44).
Samples were 100-fold diluted to culture a volume of re-
porter strain, and they were then tested to measure β-
galactosidase activity. The Miller Units from samples were
calculated as described previously (13). The measurement
of C4-HSL was conducted through violacein productions of
the Chromobacterium violaceum CV026 strain (45). The
CV026 strain was incubated in 5 ml of LB and LB supple-
mented with 100-fold diluted extract. After incubation, cell
pellets in 1 ml of culture were harvested by centrifugation
at 13,000 rpm for 3 min. The pellets were then resuspended
using HPLC grade DMSO to dissolve violacein. Violacein
was measured at 575 nm absorbance and normalized using
the OD600 value of CV026.
DNA manipulation
Primer sequences used in the study are listed in Table S2.
Plasmid preparation was performed using a Plasmid mini
extraction kit (Bioneer Inc). Restriction enzyme digestion,
ligation, and agarose gel electrophoresis were performed by
following standard methods. A Gibson assembly kit (New
England Biolabs Inc) was used in cloning to produce the
dksA1-fused 3XFLAG strain. Transformation of E. coli was
carried out by electroporation. Competent E. coli cells for
electroporation were prepared by repeated washing with
300 mM sucrose. Electroporation settings were 2.5 kV, 25 μF,
and 200 Ω for a 2 mm electroporation cuvette. The oligonu-
cleotide primers synthesis and sequencing DNA were per-
formed by Macrogen.
Antibiotic susceptibility test
Overnight cultured PAO1 was inoculated to 100-fold
dilution in 2 ml of LB supplemented with gentamicin,
imipenem, streptomycin, tetracycline, kanamycin, and
tobramycin ranging from 1 μg/ml to 25 μg/ml and 150 μM
of Dkstatin-1 or Dkstatin-2. The incubation took 6 h at 37J. Biol. Chem. (2021) 296 100576 11
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samples were serially diluted by tenfold in 1 ml of PBS, and
10 μl of each dilute was spotted onto an LB agar plate for
CFU counts. The plates were incubated overnight at 37 C
without shaking.
Western blot and immunoprecipitation
PAO1 dksA1::3xFLAG strain was grown in 20 ml of LB
medium supplemented with or without 150 μM of Dkstatin-1
and Dkstatin-2 for 6 to 8 h. Whole cells were pelleted by
centrifugation at 3000 rpm for 30 min at 4 C and were
resuspended with 600 to 800 μl of lysis buffer (50 mM Tris-
HCl pH 7.5, 75 mM NaCl, 10 mM MgCl2, 10% glycerol,
1 mM EDTA, 1 mM PMSF, and 0.01% Triton X-100) with 8 μl
of SIGMA FAST protease inhibitor cocktail (Sigma-Aldrich).
The pellets were then sonicated at 30% amplitude for 10 s with
10 s intervals on ice and were then centrifuged for 30 min at 4
C and 14,000 rpm. The supernatants of the lysates were
collected and placed into new tubes. Their volumes were
adjusted to contain equal quantities of total proteins. Then, 10
to 800 μl of the adjusted samples was used for western blots
and immunoprecipitation. For DksA1::3xFLAG blotting, 10 μl
of samples was loaded on 12% SDS-PAGE and transferred to
Amersham Protran premium 0.2 μm nitrocellulose mem-
branes (GE Healthcare Life Sciences) for 1 h in an ice-cold
transfer buffer (25 mM Tris, 192 mM glycine pH 8.3 20%
methanol (v/v)). Membranes were blocked with a 5% BSA
containing TBST solution overnight at 4 C on a rocking
shaker. Blots were incubated with anti-FLAG (Sigma-Aldrich)
and anti-rabbit secondary antibodies (Thermo-fisher) and
revealed by chemiluminescence. All washes were performed
with a TBST solution without BSA. Immunoprecipitation was
conducted using 800 μl of samples with 25 μl of M2 Anti-
FLAG magnetic beads (Sigma-Aldrich) after incubating over-
night at 4 C on a rocking shaker. Beads were pelleted using a
magnet and were washed once with the lysis buffer. Samples
bound to the beads were eluted in 30 μl of lysis buffer by
heating at 100 C for 10 min. The eluted samples were then
loaded on 10% SDS-PAGE and blotted by anti-FLAG Ab
(Sigma) or anti-E.coli RpoB Ab (Abcam).RNASeq analysis
To extract total RNA, P. aeruginosa PAO1 was incubated
for 2 h in 5 ml of LB with vigorous shaking at 37 C. Then,
additional incubation was conducted for 1 h under the same
condition with 150 μM of Dkstatin-1 or Dkstatin-2 supple-
ment. Total RNA samples were extracted using an RNeasy
mini kit (Qiagen), and total DNA was eliminated using RNase-
free DNase set (Qiagen) following the manufacturer’s in-
structions. The extraction was performed as an experimental
duplicate. Transcriptome profile comparison and processing
the expression data were provided by Ebiogen. RNA quality
was assessed by an Agilent 2100 bioanalyzer using the RNA
6000 Nano Chip (Agilent Technologies), and RNA quantifi-
cation was performed using an ND-2000 Spectrophotometer12 J. Biol. Chem. (2021) 296 100576(Thermo Inc). For control and testing RNAs, rRNA was
removed using a Ribo-Zero Magnetic kit (Epicentre Inc) from
each 5 ug of total RNA. The construction of a library was
performed using a SMARTer Stranded RNA-Seq Kit (Clon-
tech Lab Inc) according to the manufacturer’s instructions.
The rRNA-depleted RNAs were used for the cDNA synthesis
and shearing, following manufacturer’s instructions. Indexing
was performed using the Illumina indexes 1 to 12. The
enrichment step was carried out using PCR. Subsequently, li-
braries were checked using the Agilent 2100 bioanalyzer (DNA
High Sensitivity Kit) to evaluate the mean fragment size.
Quantification was performed using the library quantification
kit using a StepOne Real-Time PCR System (Life Technologies
Inc). High-throughput sequencing was performed as paired-
end 100 sequencing using HiSeq 2500 (Illumina Inc).
Bacterial-Seq reads were mapped using a Bowtie2 software
tool to obtain the alignment file. DEGs were determined based
on counts from unique and multiple alignments using EdgeR
within R (R development Core Team, 2016) using Bio-
conductor (46). The alignment file also was used for assem-
bling transcripts. The quantile normalization method was used
for comparisons between samples. Gene classification was
based on searches done by DAVID (http://david.abcc.ncifcrf.
gov/).
Mouse infection
Eight-week-old female C57BL/6 mice (Orient) were infec-
ted with PAO1 and a combination of Dksatin-1 or Dkstatin-2.
PAO1 pellets incubated in LB broth at 37 C for 6 h were
resuspended in 1 ml of sterile phosphate-buffered saline
(PBS) containing 1% of DMSO or 150 μM of Dkstatin com-
pounds, and they were adjusted to 106 cells per 20 μl as an
initial infection dose. Mice were anesthetized by injection of
20% (v/v) ketamine and 8% (v/v) Rompun mixed in saline.
During anesthetization, 20 μl of prepared bacterial cells was
inhaled directly through the nose by a pipette as previously
described (47). The survival of the mice was monitored for
48 h with 2 h intervals. The survival of the mice was
expressed as a Kaplan–Meier curve using Graph Pad Prism
software (www.graphpad.com). To measure the bacterial load
in the lungs, another set of mice (n = 4) were infected with
the same administration above. All mice were euthanized in a
CO2 gas chamber 12 h post infection. Then, whole lungs
from mice in each group were immediately collected and
homogenized for serial dilution in 1 ml of PBS. For histo-
logical observation, lungs were perfused with sterile PBS and
staining with hematoxylin and eosin was conducted following
a standard protocol (48).
Statistical analysis
Statistical analysis of the data in the experiments was carried
out by statistic tools within Graph Pad Prism software (www.
graphpad.com) for the paired Student’s t-test. A p-value of
less than 0.05 was considered statistically significant. All ex-
periments were repeated for reproducibility.
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